Format

Send to

Choose Destination
See comment in PubMed Commons below
Transplantation. 2013 Aug 15;96(3):234-8. doi: 10.1097/TP.0b013e318298f9fa.

Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.

Author information

1
Transplantation and Nephrology, Erasmus MC, Rotterdam, The Netherlands. m.franquesa@erasmusmc.nl

Erratum in

  • Transplantation. 2013 Sep;96(6):e49. Roemeling-vanRhijn, Marieke [corrected to Roemeling-van Rhijn, Marieke].

Abstract

The Fourth Expert Meeting of the Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Consortium took place in Barcelona on October 19 and 20, 2012. This meeting focused on the translation of preclinical data into early clinical settings. This position paper highlights the main topics explored on the safety and efficacy of mesenchymal stem cells as a therapeutic agent in solid organ transplantation and emphasizes the issues (proper timing, concomitant immunossupression, source and immunogenicity of mesenchymal stem cells, and oncogenicity) that have been addressed and will be followed up by the MiSOT Consortium in future studies.

PMID:
23759879
PMCID:
PMC3737392
DOI:
10.1097/TP.0b013e318298f9fa
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Support Center